Tel:
Email:

Nucleosides

2'-Modified Nucleosides
(334/334)
3'-Modified Nucleosides
(175/175)
5'-Modified Nucleosides
(290/290)
Anhydro-Nucleosides
(13/13)
Arabinonucleosides
(34/34)
Base Protected Nucleosides
(277/277)
Halogen Nucleosides
(133/133)
L-Nucleosides
(18/18)
Other Nucleosides
(88/88)
Other Protected Nucleosides
(23/23)
Ribonucleosides
(11/11)
Backbone
Modification
Base Type
Filtered by
Clear All

2'-O-Methylcytidine

Description: Cytidine analog. Used for preparation of nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase.
CAT: BRP-00010
CAS: 2140-72-9
Molecular Formula: C10H15N3O5
Molecular Weight: 257.24
Purity: ≥95%
Appearance: White Solid
Size Price Stock Quantity
25 g $369 In stock
Inquiry   
Storage: Store at 2-8°C
Density: 1.68±0.1 g/cm3 (Predicted)
Melting Point: >247°C (dec.)
Boiling Point: 506.0±60.0°C (Predicted)
Flash Point: 259.8±32.9 °C
Symbol: Cm
InChIKey: RFCQJGFZUQFYRF-ZOQUXTDFSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Heated)
CanonicalSMILES: COC1C(C(OC1N2C=CC(=NC2=O)N)CO)O
IUPAC Name: 4-amino-1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidin-2-one
InChI: InChI=1S/C10H15N3O5/c1-17-8-7(15)5(4-14)18-9(8)13-3-2-6(11)12-10(13)16/h2-3,5,7-9,14-15H,4H2,1H3,(H2,11,12,16)/t5-,7-,8-,9-/m1/s1
Synonyms: 2'-(O-Methyl) Cytidine; Cytidine, 2'-O-methyl-; 2'-O-Methyl cytidine; O(2')-Methylcytidine; 4-amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 4-Amino-1-(2-O-methyl-β-D-ribofuranosyl)pyrimidin-2(1H)-one

2'-O-Methyluridine

Description: Uridine analog. Used for preparation of antiviral nucleoside derivatives as inhibitors of subgenomic hepatitis C virus RNA replication.
CAT: BRP-00012
CAS: 2140-76-3
Molecular Formula: C10H14N2O6
Molecular Weight: 258.23
Purity: ≥95%
Appearance: White solid
Size Price Stock Quantity
25 g $239 In stock
Inquiry   
Storage: Store at 2-8 °C
Density: 1.53±0.1 g/cm3 (Predicted)
Melting Point: 154-156 °C
Symbol: Um
InChIKey: SXUXMRMBWZCMEN-ZOQUXTDFSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)
CanonicalSMILES: COC1C(C(OC1N2C=CC(=O)NC2=O)CO)O
IUPAC Name: 1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C10H14N2O6/c1-17-8-7(15)5(4-13)18-9(8)12-3-2-6(14)11-10(12)16/h2-3,5,7-9,13,15H,4H2,1H3,(H,11,14,16)/t5-,7-,8-,9-/m1/s1
Synonyms: 2'-(O-Methyl) Uridine; Uridine, 2'-O-methyl-; O(2')-Methyluridine; 1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-(2-O-Methyl-β-D-ribofuranosyl)uracil

Tubercidin

Description: Tubercidin is an adenosine analog with antiviral, antitrypanosomal, and antifungal properties. It inhibits DNA/RNA synthesis and other metabolic processes.
CAT: BRP-00018
CAS: 69-33-0
Molecular Formula: C11H14N4O4
Molecular Weight: 266.25
Purity: ≥98% by HPLC
Appearance: White Crystalline Powder
Size Price Stock Quantity
500 mg $439 In stock
Inquiry   
Storage: Store at-20°C
Density: 1.90±0.1 g/cm3
Melting Point: 247-248 °C (dec.)
Boiling Point: 648.8±55.0 °C at 760 mmHg
Application: 7-Deaza-adenosine is an adenosine analog.
Shelf Life: As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
InChIKey: HDZZVAMISRMYHH-KCGFPETGSA-N
Solubility: Soluble in Methanol
CanonicalSMILES: C1=CN(C2=NC=NC(=C21)N)C3C(C(C(O3)CO)O)O
IUPAC Name: (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C11H14N4O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2,(H2,12,13,14)/t6-,7-,8-,11-/m1/s1
Synonyms: 7-Deazaadenosine; Antibiotic XK 101-1; BRN 0038498; 7-Deaza ribo Adenosine; 7-β-D-Ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine; 4-Amino-7-(β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine; 6-Amino-9-D-ribofuranosyl-7-desazapurine; N7-Deazaadenosine; NQZ-003; NSC 56408; Sparsamycin A; Sparsomycin A; Tubercidine; U 10071

Nicotinamide riboside

Description: Nicotinamide riboside is a form of pyridine nucleoside with a nicotinamide. It is a precursor to NAD+ and a source of vitamin B3. Nicotinamide riboside increases intracellular and mitochondrial NAD+ content in C2C12, Hepa1.6, and HEK293 cells. It also activates SIRT1 and SIRT3 in vitro.
CAT: BRP-00044
CAS: 1341-23-7
Molecular Formula: C11H15N2O5
Molecular Weight: 255.25
Purity: ≥95% (Contain ~80% food grade dextrin as stabilizer)
Size Price Stock Quantity
5 g $298 In stock
Inquiry   
InChIKey: JLEBZPBDRKPWTD-TURQNECASA-O
CanonicalSMILES: C1=CC(=C[N+](=C1)C2C(C(C(O2)CO)O)O)C(=O)N
IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxamide
InChI: InChI=1S/C11H14N2O5/c12-10(17)6-2-1-3-13(4-6)11-9(16)8(15)7(5-14)18-11/h1-4,7-9,11,14-16H,5H2,(H-,12,17)/p+1/t7-,8-,9-,11-/m1/s1
Synonyms: Nicotinamide-beta-riboside; Nicotinamide ribonucleoside; N-Ribosylnicotinamide; 3-(Aminocarbonyl)-1-β-D-ribofuranosylpyridinium; Pyridinium, 3-carbamoyl-1-β-D-ribofuranosyl-; 3-Pyridinecarboxamide, 1-β-D-ribosyl-; Nicotinamide ribose; Ribosylnicotinamide

EIDD-2749

Description: 4'-Fluorouridine is an orally active RdRp inhibitor. It effectively blocks the replication of RSV and SARS-CoV-2.
CAT: BRP-00063
CAS: 1613589-24-4
Molecular Formula: C9H11FN2O6
Molecular Weight: 262.19
Purity: ≥95%
Appearance: Off-white to Yellow Solid
Size Price Stock Quantity
50 mg $339 In stock
500 mg $1399 In stock
Inquiry   
Density: 1.77±0.1 g/cm3
InChIKey: RDCYLPRXPILMRP-JVZYCSMKSA-N
CanonicalSMILES: O=C1NC(N([C@@H]2O[C@@](CO)(F)[C@@H](O)[C@H]2O)C=C1)=O
IUPAC Name: 1-[(2R,3R,4S,5S)-5-fluoro-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H11FN2O6/c10-9(3-13)6(16)5(15)7(18-9)12-2-1-4(14)11-8(12)17/h1-2,5-7,13,15-16H,3H2,(H,11,14,17)/t5-,6+,7-,9-/m1/s1
Synonyms: 4'-fluorouridine; 4'-C-Fluoro-uridine; 4'-FlU

2'-O-Methyladenosine

Description: 2'-O-Methyladenosine is a modified nucleoside where a methyl group is attached to the 2' hydroxyl of the ribose sugar. This modification enhances the stability and binding affinity of RNA molecules, making it valuable in research focused on RNA structure, function, and therapeutic development. It is commonly used in the synthesis of chemically modified RNA for studies in molecular biology and biotechnology.
CAT: BRP-00066
CAS: 2140-79-6
Molecular Formula: C11H15N5O4
Molecular Weight: 281.27
Purity: ≥95%
Appearance: White to Off-white Solid
Size Price Stock Quantity
25 g $299 In stock
Inquiry   
Storage: Store at 2-8°C
Density: 1.84±0.1 g/cm3 (Predicted)
Melting Point: 198-200°C
Boiling Point: 623.8±65.0°C (Predicted)
Symbol: Am
InChIKey: FPUGCISOLXNPPC-IOSLPCCCSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Heated, Sonicated), Water (Slightly)
CanonicalSMILES: COC1C(C(OC1N2C=NC3=C(N=CN=C32)N)CO)O
IUPAC Name: (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-ol
InChI: InChI=1S/C11H15N5O4/c1-19-8-7(18)5(2-17)20-11(8)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1
Synonyms: Adenosine, 2'-O-methyl-; (2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol; Cordysinin B; 2'-O-Methyl-D-adenosine; 2'-O-Me-adenosine; 2'-(O-Methyl) Adenosine; 2'-O-Me-Ado

2'-O,4'-C-Methyleneguanosine

Description: 2'-O,4'-C-Methyleneguanosine, a modified nucleoside molecule, has demonstrated effective outcomes in the domain of antiviral therapeutics, exemplifying excellent potential as a therapeutic agent for hepatitis C and West Nile virus infections. Substantiated by its unique mechanism of action- hindering viral RNA polymerase, a critical enzyme necessary for viral replication, it is deemed a highly potent approach for viral inhibition. Furthermore, this particular compound presents an enticing opportunity for its application as an antitumor agent, drawing interest from scientific communities.
CAT: BRP-00068
CAS: 207131-16-6
Molecular Formula: C11H13N5O5
Molecular Weight: 295.25
Purity: ≥95%
Size Price Stock Quantity
100 mg $1099 In stock
Inquiry   
Storage: Store at -20 °C
Density: 2.31±0.1 g/cm3 (Predicted)
InChIKey: OZVMOEUWPMYRQU-JUQFDLSGSA-N
CanonicalSMILES: C1C2(C(C(O1)C(O2)N3C=NC4=C3N=C(NC4=O)N)O)CO
IUPAC Name: 2-amino-9-((1S,3R,4R,7S)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-1,9-dihydro-6H-purin-6-one
InChI: InChI=1S/C11H13N5O5/c12-10-14-7-4(8(19)15-10)13-3-16(7)9-5-6(18)11(1-17,21-9)2-20-5/h3,5-6,9,17-18H,1-2H2,(H3,12,14,15,19)/t5-,6+,9-,11+/m1/s1
Synonyms: LNA-G; 2-amino-9-[(1S,3R,4R,7S)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-1H-purin-6-one; 1-(2'-O-4-C-Methylene-b-D-ribofuranosyl)guanine; 2-Amino-9-[2,5-anhydro-4-(hydroxymethyl)-α-L-lyxofuranosyl]-1,9-dihydro-6H-purin-6-one

3'-O-Methylguanosine

Description: 3'-O-Methylguanosine is an endogenous methylated nucleoside found in human fluids. Methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls. DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents. When chemical bonds to DNA, it becomes damaged and proper and complete replication cannot occur to make the normal intended cell. A DNA adduct is an abnormal piece of DNA covalently-bonded to a cancer-causing chemical. This has shown to be the start of a cancerous cell, or carcinogenesis. DNA adducts in scientific experiments are used as bio-markers and as such are themselves measured to reflect quantitatively, for comparison, the amount of cancer in the subject.
CAT: BRP-00077
CAS: 10300-27-3
Molecular Formula: C11H15N5O5
Molecular Weight: 297.27
Purity: ≥95%
Appearance: White to Off-white Powder to Crystalline Powder
Size Price Stock Quantity
50 mg $168 In stock
Inquiry   
Storage: Store at 2-8°C
Density: 1.98±0.10 g/cm3
Melting Point: 263-300 °C
Boiling Point: 711.7 °C at 760 mmHg
InChIKey: UYARPHAXAJAZLU-KQYNXXCUSA-N
Solubility: In Vitro:
DMSO : 25 mg/mL(84.10 mM;ultrasonic and warming and heat to 60°C)
CanonicalSMILES: COC1C(OC(C1O)N2C=NC3=C2N=C(NC3=O)N)CO
IUPAC Name: 2-amino-9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C11H15N5O5/c1-20-7-4(2-17)21-10(6(7)18)16-3-13-5-8(16)14-11(12)15-9(5)19/h3-4,6-7,10,17-18H,2H2,1H3,(H3,12,14,15,19)/t4-,6-,7-,10-/m1/s1
Synonyms: 3'-(O-Methyl) Guanosine; 3'-O-Methyl-D-guanosine; 3'-O-Methyl guanosine; O3'-methyl-guanosine; 3'-OMe-G; 2-amino-9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl]-3,9-dihydro-6H-purin-6-one

3'-O-(2-Methoxyethyl)guanosine

Description: 3'-O-(2-Methoxyethyl)guanosine is a remarkable modified nucleoside with immense potential in the field of antiviral drug discovery. This exquisite compound takes center stage in targeting viral RNA-dependent RNA polymerases, thus rendering it a powerful weapon in research of respiratory syncytial virus (RSV) and hepatitis C virus (HCV).
CAT: BRP-00078
CAS: 256224-03-0
Molecular Formula: C13H19N5O6
Molecular Weight: 341.32
Purity: ≥95%
Size Price Stock Quantity
2 g $1980 In stock
Inquiry   
Density: 1.81±0.1 g/cm3
InChIKey: DQZXNLOSGQCAEG-LYECJJOESA-N
CanonicalSMILES: COCCOC1C(OC(C1O)N2C=NC3C2=NC(=N)NC3=O)CO
IUPAC Name: 9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-(2-methoxyethoxy)oxolan-2-yl]-2-imino-5H-purin-6-one
InChI: InChI=1S/C13H19N5O6/c1-22-2-3-23-9-6(4-19)24-12(8(9)20)18-5-15-7-10(18)16-13(14)17-11(7)21/h5-9,12,19-20H,2-4H2,1H3,(H2,14,17,21)/t6-,7?,8-,9-,12-/m1/s1
Synonyms: Guanosine, 3'-O-(2-methoxyethyl)-; 3'-O-MOE-G; 2-Amino-9-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-(2-methoxyethoxy)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one

2'-O-(2-Methoxyethyl)adenosine

Description: It is a derivative of adenosine that acts as a building block for crosslinking oligonucleotides.
CAT: BRP-00082
CAS: 168427-74-5
Molecular Formula: C13H19N5O5
Molecular Weight: 325.32
Purity: ≥95%
Appearance: White Solid
Size Price Stock Quantity
1 g $259 In stock
Inquiry   
Storage: Store at -20°C under inert atmosphere
Density: 1.701±0.1 g/cm3 (Predicted)
Melting Point: 54-59°C
Boiling Point: 639.0±65.0°C (Predicted)
InChIKey: PUDXUJRJLRLJIU-QYVSTXNMSA-N
Solubility: Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
CanonicalSMILES: COCCOC1C(C(OC1N2C=NC3=C(N=CN=C32)N)CO)O
IUPAC Name: (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)oxolan-3-ol
InChI: InChI=1S/C13H19N5O5/c1-21-2-3-22-10-9(20)7(4-19)23-13(10)18-6-17-8-11(14)15-5-16-12(8)18/h5-7,9-10,13,19-20H,2-4H2,1H3,(H2,14,15,16)/t7-,9-,10-,13-/m1/s1
Synonyms: (2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-ol; Adenosine, 2'-O-(2-methoxyethyl)-; 2'-O-methoxyethyl Adenosine; 2'-O-MOE-A; 2'-O-MOE-Adenosine; 2'-O-MOE-rA

2'-O-(2-Methoxyethyl)guanosine

Description: It is a guanosine derivative as a building block for crosslinking oligonucleotides.
CAT: BRP-00084
CAS: 473278-54-5
Molecular Formula: C13H19N5O6
Molecular Weight: 341.32
Purity: ≥95%
Appearance: White to Off-white Crystalline Powder
Size Price Stock Quantity
1 g $176 In stock
Inquiry   
Storage: Store at -20°C
Density: 1.81±0.1 g/cm3 (Predicted)
Boiling Point: 715.0±70.0°C (Predicted)
InChIKey: VORWLCQFVYLMRX-LYECJJOESA-N
CanonicalSMILES: COCCOC1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)CO)O
IUPAC Name: 2-amino-9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C13H19N5O6/c1-22-2-3-23-9-8(20)6(4-19)24-12(9)18-5-15-7-10(18)16-13(14)17-11(7)21/h5-9,12,19-20H,2-4H2,1H3,(H2,14,17,21)/t6-,7?,8-,9-,12-/m1/s1
Synonyms: Guanosine, 2'-O-(2-methoxyethyl)-; 2-Amino-9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-3H-purin-6(9H)-one; 2'-MOE-rG; 2'-O-Methoxyethyl-guanosine; 2'-O-MOE-rG

5'-O-DMT-uridine

Description: It is used for nucleoside modification and RNA synthesis.
CAT: BRP-00113
CAS: 81246-79-9
Molecular Formula: C30H30N2O8
Molecular Weight: 546.57
Purity: ≥98% by HPLC
Appearance: White Solid
Size Price Stock Quantity
100 g $899 In stock
Inquiry   
Storage: Store at 2-8°C
Density: 1.343±0.06 g/cm3(Predicted)
Melting Point: 111-112 °C
InChIKey: PCFSNQYXXACUHM-YULOIDQLSA-N
Solubility: Soluble in Ethyl Acetate
CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=CC(=O)NC5=O)O)O
IUPAC Name: 1-[(2R,3R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3,4-dihydroxyoxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C30H30N2O8/c1-37-22-12-8-20(9-13-22)30(19-6-4-3-5-7-19,21-10-14-23(38-2)15-11-21)39-18-24-26(34)27(35)28(40-24)32-17-16-25(33)31-29(32)36/h3-17,24,26-28,34-35H,18H2,1-2H3,(H,31,33,36)/t24-,26-,27-,28-/m1/s1
Synonyms: 5'-DMT Uridine; 5'-O-DMT uridine; 5'-O-(4,4'-Dimethyltrityl)uridine; 5'-O-DMT-D-uridine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]uridine; 1-((2R,3R,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

N2-DMF-2'-O-methylguanosine

Description: N2-DMF-2'-O-methylguanosine, an indispensable biomedical resource, showcases remarkable efficacy in combating targeted illnesses. Its distinctive composition as a modified nucleoside endows it with unparalleled potential in countering RNA viruses. Addressing the pressing need for effective antiviral treatments, especially for respiratory syncytial virus (RSV) and influenza, this compound serves as a pivotal asset in formulating groundbreaking therapies.
CAT: BRP-00154
CAS: 183737-04-4
Molecular Formula: C14H20N6O5
Molecular Weight: 352.35
Purity: ≥97% by HPLC
Size Price Stock Quantity
1 g $299 In stock
Inquiry   
Density: 1.6±0.1 g/cm3
InChIKey: KDQQTCFKBCWYFL-QYVSTXNMSA-N
CanonicalSMILES: CN(C)C=NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)OC
IUPAC Name: N'-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
InChI: InChI=1S/C14H20N6O5/c1-19(2)5-16-14-17-11-8(12(23)18-14)15-6-20(11)13-10(24-3)9(22)7(4-21)25-13/h5-7,9-10,13,21-22H,4H2,1-3H3,(H,17,18,23)/t7-,9-,10-,13-/m1/s1
Synonyms: DMF-2'-OMe-G; N2-[(dimethylamino)methylidene]-2'-O-methyl-D-guanosine; N2-DMF-2'-O-methyl-D-guanosine; N2-DMF-2'-OMe-rG; Guanosine, N-[(dimethylamino)methylene]-2'-O-methyl-; N-(Dimethylaminomethylene)-2'-O-methylguanosine

N4-Benzoyl-5'-O-DMT-2'-O-methylcytidine

Description: N4-Benzoyl-5'-O-DMT-2'-O-methylcytidine, an influential antiviral agent extensively employed in the biomedical sector, showcases remarkable efficacy in combating RNA viral infections. Its valuable contributions lie in its capacity to combat diverse viral strains, thereby enlightening researchers on viral replication processes and fostering the advancement of groundbreaking antiviral treatments.
CAT: BRP-00164
CAS: 110764-74-4
Molecular Formula: C38H37N3O8
Molecular Weight: 663.72
Purity: ≥95%
Appearance: White to Light Yellow Powder
Size Price Stock Quantity
5 g $469 In stock
10 g $788 In stock
Inquiry   
Storage: Store at -20°C
Density: 1.27±0.1 g/cm3 (Predicted)
InChIKey: WXJKGOQQYUVNQW-YDXJMRNDSA-N
CanonicalSMILES: COC1C(C(OC1N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O
IUPAC Name: N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide
InChI: InChI=1S/C38H37N3O8/c1-45-29-18-14-27(15-19-29)38(26-12-8-5-9-13-26,28-16-20-30(46-2)21-17-28)48-24-31-33(42)34(47-3)36(49-31)41-23-22-32(40-37(41)44)39-35(43)25-10-6-4-7-11-25/h4-23,31,33-34,36,42H,24H2,1-3H3,(H,39,40,43,44)/t31-,33-,34-,36-/m1/s1
Synonyms: N4-Bz-DMT-2'-OMe-Cr; 5'-DMT-2'-(O-Methyl) Cytidine (n-bz); 5'-O-DMTr-2'-O-Me-rC(Bz); N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-methycytidine; N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-methylcytidine; 5'-O-DMT-N4-Benzoyl-2'-O-Methyl-Cytidine; DMT-2'-OMe-Bz-C; 5'-O-[alpha,alpha-Bis(4-methoxyphenyl)benzyl]-N-benzoyl-2'-O-methylcytidine

5'-O-DMT-N2-isobutyrylguanosine

Description: 5'-O-DMT-N2-isobutyrylguanosine is a biomedicine product commonly used in the field of nucleic acid research. This compound is a modified form of guanosine and is often utilized as a substrate to study various enzymatic reactions related to DNA and RNA synthesis. It plays a crucial role in investigating the functions of guanine derivatives, offering insights into potential therapeutic approaches for diseases involving nucleic acid metabolism.
CAT: BRP-00169
CAS: 81246-83-5
Molecular Formula: C35H37N5O8
Molecular Weight: 655.70
Purity: ≥95%
Appearance: Pale Yellow Solid
Size Price Stock Quantity
25 g $348 In stock
100 g $629 In stock
Inquiry   
Storage: Store at 2-8°C
Density: 1.4±0.1 g/cm3
Melting Point: >153°C
Boiling Point: 892.9±75.0°C at 760 mmHg
InChIKey: SSYBHRGSXXKZQZ-QBVBFOPXSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)
CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)O
IUPAC Name: N-(9-((2R,3R,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
InChI: InChI=1S/C35H37N5O8/c1-20(2)31(43)38-34-37-30-27(32(44)39-34)36-19-40(30)33-29(42)28(41)26(48-33)18-47-35(21-8-6-5-7-9-21,22-10-14-24(45-3)15-11-22)23-12-16-25(46-4)17-13-23/h5-17,19-20,26,28-29,33,41-42H,18H2,1-4H3,(H2,37,38,39,43,44)/t26-,28-,29-,33-/m1/s1
Synonyms: 5'-DMT-ibu-rG; N2-iso-Butyryl-5'-O-(4,4'-dimethoxytrityl)guanosine; 5'-O-(4,4'-Dimethoxytrityl)-N2-isobutyryl-2'-guanosine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-N-(2-methyl-1-oxopropyl)-guanosine; N-[9-[(2R,3R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3,4-dihydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide; 5'-O-DMT-ibu-rG; 5'-DMT Guanosine (n-ibu)

1-MethylpseudoUridine

Description: N1-methyl-pseudoUridine (1-Methylpseudouridine), a methylpseudoUridine, outperforms 5 mC and 5 mC/N1-methyl-pseudoUridine in translation. N1-methyl-pseudoUridine in mRNA enhances translation through eIF2α-dependent and independent mechanisms by increasing ribosome density.
CAT: BRP-00238
CAS: 13860-38-3
Molecular Formula: C10H14N2O6
Molecular Weight: 258.23
Purity: ≥95%
Appearance: White to pale pink powder
Size Price Stock Quantity
1 g $367 In stock
Inquiry   
Storage: Storage at 2-8°C
Density: 1.6±0.1 g/cm3
Symbol: m1Ψ
InChIKey: UVBYMVOUBXYSFV-XUTVFYLZSA-N
CanonicalSMILES: CN1C=C(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
IUPAC Name: 5-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1-methylpyrimidine-2,4-dione
InChI: InChI=1S/C10H14N2O6/c1-12-2-4(9(16)11-10(12)17)8-7(15)6(14)5(3-13)18-8/h2,5-8,13-15H,3H2,1H3,(H,11,16,17)/t5-,6-,7-,8+/m1/s1
Synonyms: N1-Methylpseudouridine; 2,4(1H,3H)-Pyrimidinedione, 1-methyl-5-b-D-ribofuranosyl-; (-)-1-Methyl-5-(β-D-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione; Antibiotic U-50228; U-50228; 1-N-Me-pseudouridine; (1S)-1,4-anhydro-1-(1-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-D-ribitol; Uracil, 1-methyl-5-b-D-ribofuranosyl-

β-pseudoUridine

Description: An isomer of the nucleoside uridine found in all species and in many classes of RNA except mRNA. It is formed by enzymes called synthases, which post-transcriptionally isomerize specific uridine residues in RNA in a process termed pseudouridylation. Studies suggest that Beta-Pseudouridine reduces radiation-induced chromosome aberrations in human lymphocytes.
CAT: BRP-00315
CAS: 1445-07-4
Molecular Formula: C9H12N2O6
Molecular Weight: 244.20
Purity: 98%
Appearance: White to Off-white Solid
Size Price Stock Quantity
5 g $198 In stock
Inquiry   
Storage: Store at 2-8°C
Density: 1.641±0.06 g/cm3 (Predicted)
Melting Point: 212-214°C
Boiling Point: 598.4±60.0 °C at 760 mmHg
Symbol: Ψ
InChIKey: PTJWIQPHWPFNBW-GBNDHIKLSA-N
Solubility: Soluble in Methanol (Very Slightly, Heated), Water (Slightly, Sonicated, Heated)
CanonicalSMILES: C1=C(C(=O)NC(=O)N1)C2C(C(C(O2)CO)O)O
IUPAC Name: 5-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-pyrimidine-2,4-dione
InChI: InChI=1S/C9H12N2O6/c12-2-4-5(13)6(14)7(17-4)3-1-10-9(16)11-8(3)15/h1,4-7,12-14H,2H2,(H2,10,11,15,16)/t4-,5-,6-,7+/m1/s1
Synonyms: Pseudouridine; ψ-Uridine; 5-(β-D-Ribofuranosyl)uracil; b-pseudoUridine; 5-β-D-Ribofuranosyl-2,4(1H,3H)-Pyrimidinedione; 5-Ribosyluracil; NSC 162405; Pseudouridine C; β-D-Pseudouridine; pseudo-Uridine; Pseudouracil; Pseudouridine; β-Pseudouridine; 5-((2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

2'-O-(2-Propyn-1-yl)adenosine

Description: 2'-O-(2-Propyn-1-yl)adenosine is a revolutionary modified adenosine derivative that has been extensively utilized in studying a multitude of ailments, encompassing cancer, viral infections and neurological disorders.
CAT: BRP-00359
CAS: 151390-97-5
Molecular Formula: C13H15N5O4
Molecular Weight: 305.29
Purity: ≥95%
Size Price Stock Quantity
100 mg $399 In stock
Inquiry   
Storage: Store at 2-8 °C
Density: 1.65±0.1 g/cm3 (Predicted)
Boiling Point: 655.1±65.0°C (Predicted)
InChIKey: ROHGEAZREAFNTO-QYVSTXNMSA-N
CanonicalSMILES: C#CCOC1C(C(OC1N2C=NC3=C(N=CN=C32)N)CO)O
IUPAC Name: (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-prop-2-ynoxyoxolan-3-ol
InChI: InChI=1S/C13H15N5O4/c1-2-3-21-10-9(20)7(4-19)22-13(10)18-6-17-8-11(14)15-5-16-12(8)18/h1,5-7,9-10,13,19-20H,3-4H2,(H2,14,15,16)/t7-,9-,10-,13-/m1/s1
Synonyms: 2'-O-propargyl-rA; 2'-O-Propargyladenosine; 2'-O-2-propynyl-Adenosine; (2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-(prop-2-yn-1-yloxy)tetrahydrofuran-3-ol; 2'-O-2-Propyn-1-yladenosine; 2'-O-propargyl-adenosine; 2'-Propargyladenosine; 2'-O-propargyl-2-amino-Ar; 2'-O-2-Propyn-1-yladenosine; Adenosine, 2'-O-2-propynyl-; 2'-O-(1-Propyn-3-yl)adenosine; 2'-(O-propargyl) Adenosine

3'-O-(t-Butyldimethylsilyl)-2'-O-methyluridine

Description: 3'-O-(t-Butyldimethylsilyl)-2'-O-methyluridine is a biochemical compound widely used in the biomedical industry. This product is utilized in the development of antiviral drugs and therapies for treating viral infections such as hepatitis and HIV. Its unique properties make it a valuable tool for researchers studying nucleotide modifications and their impact on RNA function.
CAT: BRP-00361
CAS: 171268-84-1
Molecular Formula: C16H28N2O6Si
Molecular Weight: 372.49
Purity: ≥95%
Appearance: White to Off-white Powder
Size Price Stock Quantity
5 g $498 In stock
Inquiry   
Storage: Store at 2-8°C
Density: 1.20±0.1 g/cm3 (Predicted)
InChIKey: VWMFRWSCFRRALN-FMKGYKFTSA-N
CanonicalSMILES: CC(C)(C)[Si](C)(C)OC1C(OC(C1OC)N2C=CC(=O)NC2=O)CO
IUPAC Name: 1-[(2R,3R,4R,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C16H28N2O6Si/c1-16(2,3)25(5,6)24-12-10(9-19)23-14(13(12)22-4)18-8-7-11(20)17-15(18)21/h7-8,10,12-14,19H,9H2,1-6H3,(H,17,20,21)/t10-,12-,13-,14-/m1/s1
Synonyms: Uridine, 3'-O-[(1,1-dimethylethyl)dimethylsilyl]-2'-O-methyl-; 2'-O-Methyl-3'-O-(tert-butyldimethylsilyl)uridine; 1-((2R,3R,4R,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 3'-O-TBDMS-2'-OMe-U; 3'-O-[Dimethyl(2-methyl-2-propanyl)silyl]-2'-O-methyluridine; 3'-TBDMS-2'-O-Me-rU

3'-O-(t-Butyldimethylsilyl)-2'-deoxy-2'-fluorouridine

Description: 3'-O-(t-Butyldimethylsilyl)-2'-deoxy-2'-fluorouridine is a highly complex and perplexing compound, playing a pivotal role in combatting viruses. Notably, it showcases exceptional selectivity and efficacy against viral replication and tumor proliferation, thereby emerging as an indispensable asset in the development of antiviral medicines and anticancer researchs.
CAT: BRP-00366
CAS: 1445379-59-8
Molecular Formula: C15H25FN2O5Si
Molecular Weight: 360.45
Purity: ≥95%
Size Price Stock Quantity
1 g $399 In stock
Inquiry   
Storage: Store at 2-8 °C
Density: 1.2±0.1 g/cm3
InChIKey: KKWGVZHEXOEALO-OJAKKHQRSA-N
CanonicalSMILES: CC(C)(C)[Si](C)(C)OC1C(OC(C1F)N2C=CC(=O)NC2=O)CO
IUPAC Name: 1-[(2R,3R,4R,5R)-4-[tert-butyl(dimethyl)silyl]oxy-3-fluoro-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C15H25FN2O5Si/c1-15(2,3)24(4,5)23-12-9(8-19)22-13(11(12)16)18-7-6-10(20)17-14(18)21/h6-7,9,11-13,19H,8H2,1-5H3,(H,17,20,21)/t9-,11-,12-,13-/m1/s1
Synonyms: 1-((2R,3R,4R,5R)-4-((tert-Butyldimethylsilyl)oxy)-3-fluoro-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 2'-Deoxy-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-2'-fluorouridine; Uridine, 2'-deoxy-3'-O-[(1,1-dimethylethyl)dimethylsilyl]-2'-fluoro-; 3'-O-TBDMS-2'-F-dU

Nucleosides are fundamental building blocks in DNA and RNA synthesis, serving as the chemical precursors for oligonucleotide assembly and enzymatic transcription processes. In both solid-phase oligo synthesis and enzymatic reactions, the structure, purity, and protection strategy of nucleosides have a direct impact on coupling efficiency, sequence fidelity, and overall synthesis performance. As nucleic acid technologies continue to advance, selecting high-quality nucleosides has become increasingly important for achieving reliable and reproducible results. We offer a comprehensive range of high-quality nucleosides to support DNA and RNA synthesis across diverse applications and scales.

Overview of Nucleosides

Nucleosides consist of a nitrogenous base linked to a sugar moiety and form the core structural unit of nucleic acids. In DNA and RNA synthesis, nucleosides serve as the starting materials for the preparation of nucleotides and phosphoramidites, making them essential raw materials in both chemical and enzymatic synthesis pathways. Understanding the chemical nature of nucleosides and their functional role in synthesis workflows is critical for effective nucleic acid production.

Structure of Nucleosides

A nucleoside is composed of a heterocyclic base—adenine, guanine, cytosine, thymine, or uracil—attached to a pentose sugar via a glycosidic bond. In DNA nucleosides, the sugar is 2'-deoxyribose, while RNA nucleosides contain ribose, which includes a hydroxyl group at the 2' position. This structural difference influences chemical reactivity, stability, and downstream synthesis strategies.

Nucleosides vs Nucleotides

Nucleosides differ from nucleotides in that they do not contain a phosphate group. Nucleotides are formed when one or more phosphate groups are added to the nucleoside, enabling participation in enzymatic reactions such as transcription and polymerization. In chemical synthesis workflows, nucleosides are first chemically modified and protected before being converted into activated forms, such as phosphoramidites, for oligonucleotide assembly.

Role of Nucleosides in DNA and RNA Synthesis

In solid-phase oligonucleotide synthesis, nucleosides serve as the chemical foundation for generating phosphoramidites that are sequentially coupled to form defined DNA or RNA sequences. In enzymatic processes, nucleoside-derived nucleotides are incorporated by polymerases to produce nucleic acids. Across both approaches, nucleoside quality—including purity, structural integrity, and proper protection—directly affects synthesis efficiency, sequence accuracy, and overall yield.

Our Nucleoside Portfolio

Our nucleoside portfolio is designed to support a wide range of DNA and RNA synthesis workflows, from routine oligonucleotide assembly to advanced nucleic acid chemistry. We supply carefully selected nucleosides with controlled purity, well-defined structures, and reliable availability, enabling consistent performance in both chemical synthesis and enzymatic applications. By offering multiple nucleoside types and modification options, we help customers select materials that align with their synthesis strategy, performance requirements, and scale.

1DNA Nucleosides

DNA nucleosides are fundamental building blocks used in the synthesis of DNA oligonucleotides, serving as key starting materials for downstream modification and phosphoramidite preparation.

  • Standard DNA nucleosides including deoxyadenosine, deoxycytidine, deoxyguanosine, and thymidine
  • High chemical purity to support reliable downstream synthesis
  • Structurally verified to ensure consistency in oligonucleotide assembly
  • Suitable for routine DNA synthesis and process development workflows
  • Compatible with common solid-phase oligonucleotide synthesis platforms

2RNA Nucleosides

RNA nucleosides are designed to meet the specific chemical requirements of RNA synthesis, where the presence of the reactive 2'-hydroxyl group requires enhanced control over quality and handling.

  • Ribonucleosides suitable for RNA oligonucleotide synthesis
  • High structural integrity to support further protection and functionalization
  • Controlled purity to minimize side reactions during synthesis
  • Designed for efficient RNA chain assembly
  • Suitable for RNA research and synthesis workflow development

3Modified Nucleosides

Modified nucleosides are used to introduce specific chemical or functional properties into DNA and RNA oligonucleotides, enabling advanced applications beyond standard nucleic acid structures.

  • Base- or sugar-modified nucleosides for customized oligonucleotide design
  • Support enhanced stability, binding affinity, or functional performance
  • Suitable for specialized research and method development
  • Consistent quality to ensure reproducible modification outcomes
  • Compatible with downstream synthesis and conversion processes

4Protected Nucleosides

Protected nucleosides are chemically modified to control reactivity during oligonucleotide synthesis, enabling selective coupling and efficient assembly of defined sequences.

  • Nucleosides with established protecting group strategies
  • Designed to prevent unwanted side reactions during synthesis
  • High purity and controlled protection profiles
  • Suitable for preparation of phosphoramidites and other activated intermediates
  • Reliable performance in solid-phase DNA and RNA synthesis workflows

Applications of Nucleosides in DNA and RNA Synthesis

Nucleosides are core raw materials used across a wide range of DNA and RNA synthesis applications, providing the chemical foundation for oligonucleotide assembly and nucleic acid modification. Their structure, purity, and suitability for downstream functionalization directly influence synthesis efficiency, sequence accuracy, and overall workflow performance.

Standard Oligo Synthesis

Nucleosides are essential starting materials for the routine synthesis of DNA and RNA oligonucleotides, serving as precursors for phosphoramidite preparation and chain assembly.

• Oligonucleotide synthesis: Foundation for stepwise DNA and RNA sequence construction

• Structural integrity: Well-defined nucleoside structures to ensure sequence fidelity

• Synthesis efficiency: Reliable performance in standard solid-phase workflows

• Platform compatibility: Suitable for common automated oligonucleotide synthesizers

• Reproducibility: Consistent behavior across different sequence designs

Modified RNA and Functional Oligos

Modified nucleosides are widely used to introduce functional or chemical diversity into RNA and DNA oligonucleotides, enabling specialized properties beyond natural nucleic acids.

• Modified RNA synthesis: Support incorporation of chemically modified nucleosides

• Functional oligos: Enable enhanced stability, binding, or activity

• Custom sequence design: Facilitate tailored oligonucleotide structures

• Controlled modification: Consistent quality to ensure predictable modification outcomes

• Compatibility: Suitable for downstream conversion and assembly processes

Research and Process Development

Nucleosides play a key role in research and process development activities, where flexibility, consistency, and reliable performance are required for method optimization.

• Method development: Support optimization of synthesis and modification strategies

• Process evaluation: Enable comparison of synthesis conditions and reagents

• Scalability assessment: Suitable for transition from small-scale studies to larger workflows

• Reproducibility testing: Reliable materials for repeated experimental runs

• Workflow optimization: Compatible with evolving synthesis platforms and protocols

Quality Standards

The quality of nucleosides is a critical factor in DNA and RNA synthesis, as it directly influences downstream modification, activation, and oligonucleotide assembly. Consistent quality standards are essential to ensure reliable chemical behavior, predictable reaction outcomes, and reproducible synthesis performance. High-quality nucleosides help minimize variability during synthesis workflows and support accurate sequence construction across research and process development applications.

Purity and Structural Integrity

Nucleosides used in nucleic acid synthesis must exhibit high chemical purity and well-defined molecular structure to perform reliably in downstream reactions. Impurities or structural deviations can interfere with protection, activation, or coupling steps, leading to reduced synthesis efficiency or inconsistent results. Maintaining strict control over purity and structural integrity ensures that nucleosides behave predictably during synthesis and support accurate DNA and RNA assembly.

Protecting Group Stability

For nucleosides intended for chemical modification and oligonucleotide synthesis, the stability of protecting groups is a key quality attribute. Protecting groups must remain intact under storage and handling conditions while allowing controlled removal during synthesis. Stable and well-characterized protecting groups help prevent premature side reactions, support efficient coupling, and ensure consistent performance throughout DNA and RNA synthesis workflows.

Why Choose Our Nucleosides

  • High Purity: Manufactured to meet strict purity requirements to support reliable downstream modification and synthesis.
  • Structural Accuracy: Well-defined base and sugar structures ensure predictable chemical behavior in DNA and RNA synthesis.
  • Protecting Group Compatibility: Designed to support stable protection strategies and controlled deprotection during synthesis.
  • Batch Consistency: Controlled manufacturing processes ensure reproducible performance across different production lots.
  • Synthesis Readiness: Suitable as starting materials for phosphoramidite preparation and oligonucleotide assembly workflows.
  • Reliable Supply: Stable production and availability support ongoing research and process development needs.

Get Started with Nucleosides

Selecting the right nucleosides is an important step in achieving reliable DNA and RNA synthesis, as material quality directly affects downstream modification, coupling efficiency, and overall workflow reproducibility. Whether you are sourcing nucleosides for routine oligonucleotide synthesis or for more specialized research and process development applications, our team can support product selection, provide detailed specifications, and assist with availability and technical questions—contact us to discuss your requirements and request further information.

Frequently Asked Questions (FAQ)

What are nucleosides used for?

Nucleosides are base molecules used as starting materials for synthesizing nucleotides and phosphoramidites.

What is the difference between nucleosides and nucleotides?

Nucleosides lack phosphate groups, while nucleotides contain one or more phosphates required for enzymatic reactions.

Are nucleosides used directly in enzymatic reactions?

Nucleosides are typically chemically modified before being used in enzymatic workflows.

Can nucleosides be chemically modified?

Yes, modified nucleosides are widely used to introduce structural or functional changes in nucleic acids.

Why is nucleoside purity important?

High purity ensures correct downstream synthesis of nucleotides and phosphoramidites with predictable performance.

Nucleoside Knowledge Center

* Only for research. Not suitable for any diagnostic or therapeutic use.

Our Products

Online Inquiry
Verification code
Inquiry Basket